Filing Details
- Accession Number:
- 0001144204-17-047126
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 21:13:41
- Reporting Period:
- 2017-09-05
- Accepted Time:
- 2017-09-07 21:13:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1603584 | Lee Larry Miller | 300 Frank W. Burr Blvd. Ste 21 Teaneck NJ 07666 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2017-09-05 | 4,237 | $11.83 | 4,237 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-05 | 4,237 | $35.55 | 0 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-05 | 810 | $11.83 | 810 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-05 | 810 | $36.49 | 0 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-06 | 8,587 | $11.83 | 8,587 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 8,587 | $34.97 | 0 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-07 | 8,236 | $11.83 | 8,236 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-07 | 8,236 | $35.68 | 0 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-07 | 10,589 | $11.83 | 10,589 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-07 | 10,589 | $35.96 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Option to purchase Common Stock | Disposition | 2017-09-05 | 5,047 | $0.00 | 5,047 | $11.83 |
Class A Common Stock | Option to purchase Common Stock | Disposition | 2017-09-06 | 8,587 | $0.00 | 8,587 | $11.83 |
Class A Common Stock | Option to purchase Common Stock | Disposition | 2017-09-07 | 18,825 | $0.00 | 18,825 | $11.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
167,453 | 2013-04-29 | 2019-02-28 | No | 4 | M | Direct |
158,866 | 2013-04-29 | 2019-02-28 | No | 4 | M | Direct |
140,041 | 2013-04-29 | 2019-02-28 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.10, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.35 to $36.65, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.70 to $35.20, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.88, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.90 to $36.10, inclusive.